Medicare gets clearer rules for AI-powered health monitors
H.R. 193 — Maintaining Innovation and Safe Technologies Act · Filed by David Schweikert (R-AZ) · Introduced Jan 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to issue guidance by January 1, 2027, clarifying Medicare payment rules for remote monitoring devices (like continuous glucose monitors) that use artificial intelligence to adjust readings and transmit data to doctors. The bill does not change payment amounts or eligibility—it only requires the agency to publish clear rules so providers and device makers know what Medicare will cover.
Why we flagged it
The bill is a narrow procedural mandate requiring the agency to publish guidance on an existing payment authority. It does not create new law, change payment rates, or establish new eligibility criteria—it only directs HHS to clarify how existing Medicare rules apply to a specific class of devices.
What the text implies
- Guidance may establish de facto reimbursement standards that influence device design and market competition among remote monitoring manufacturers.
- Clarity on AI-component payment may accelerate adoption of AI-enhanced monitoring, shifting the cost burden to Medicare and potentially affecting program spending.
The full analysis lists 3 implications of this text.
Who stands to gain
remote monitoring device manufacturers; continuous glucose monitor makers; healthcare providers billing for remote monitoring services